
Research Memo: Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Supplement to Response to Request for Technical Assistance
Policy
In June 2025, LDI Executive Director Rachel M. Werner, MD, PhD, LDI Director of Research Norma Coe, PhD, and LDI Senior Fellow Eric T. Roberts, PhD collaborated with researchers at Yale School of Public Health in response to a request for technical assistance from the Senate Finance Committee and the Senate Committee on Health, Education, Labor & and Pensions (HELP) regarding the potential mortality effects of several provisions in the House-passed reconciliation bill.
The researchers project that implementation of the retractions outlined in the reconciliation bill would result in more than 42,500 deaths annually.
Additionally, the proposed bill fails to extend the Enhanced ACA Premium Tax Credits. Including that impact, the researchers project that these changes will result in over 51,000 preventable deaths.
June 3, 2025
The Honorable Ron Wyden
United States Senate
Washington, DC 20510-2105
The Honorable Bernie Sanders
United States Senate
Washington, DC 20510-2105
Dear Ranking Members Wyden and Sanders:
Thank you for your inquiry about the potential mortality impacts that would result from several provisions of the House-passed budget reconciliation bill.
In response, we estimated the number of lives that could be lost based on three effects of the reconciliation bill: (1) an estimated 7.7 million people losing Medicaid or Affordable Care Act Marketplace coverage in 2034 (as estimated by the Congressional Budget Office’s May 11, 2025 communication), (2) 1.38 million dual-eligible beneficiaries losing Medicaid coverage from disenrollment in the Medicare Savings Programs (as estimated by the CBO in their May 7, 2025 communication), and (3) immediately rescinding the CMS rule setting a national floor for minimum nursing home staffing levels.
We project that implementation of the retractions outlined in the reconciliation bill would result in more than 42,500 deaths annually. This includes:
To calculate these, we used peer-reviewed estimates of the relationship between mortality and (1) loss of Medicaid coverage for adults aged 19-64; (2) loss of medication coverage for low-income Medicare beneficiaries through the low-income subsidy;4 and (3) rescinding minimum nursing home staffing levels for total nurse staffing hours per resident day. We applied these estimates to the number of people at risk from these provisions. Because each of these three provisions affect distinct groups (1) individuals who lose all Medicaid coverage; (2) community-dwelling individuals who lose Medicaid coverage but retain Medicare coverage; and (3) individuals residing in nursing homes with lower staffing levels, we sum these projections together to a total number of 42,500 deaths in one year.
In addition, the proposed bill fails to extend the Enhanced ACA Premium Tax Credits. Expiration of this policy is expected to lead to the loss of insurance for another 5 million people, bringing the total number of uninsured individuals to 13.7 million. We calculate that this retraction will cause an additional 8,811 deaths.
Altogether, we project that these changes will result in over 51,000 preventable deaths.
Further details on these calculations can be found in the notes and supplemental documents linked below. We would be happy to discuss these findings or provide additional information that might be helpful.
Thank you for the opportunity to use this evidence to inform your work.
Sincerely,
Rachel M. Werner, MD, PhD
Executive Director, LDI
Eilers Professor in Health Care Management and Economics
Professor, Medicine
University of Pennsylvania
rwerner@upenn.edu
Norma B. Coe, PhD
Director of Research, LDI
Professor, Medical Ethics and Health Policy
University of Pennsylvania
nbcoe@pennmedicine.upenn.edu
Eric T. Roberts, PhD
Senior Fellow, LDI
Associate Professor, Division of General Internal Medicine
eric.roberts@pennmedicine.upenn.edu
Alison Galvani, PhD
Director, Center for Infectious Disease Modeling and Analysis (CIDMA)
Burnett and Stender Families Professor of Epidemiology
Yale School of Public Health
alison.galvani@yale.edu
Abhishek Pandey, PhD
Associate Director, Center for Infectious Disease Modeling and Analysis (CIDMA)
Research Scientist
Yale School of Public Health
abhishek.pandey@yale.edu
Yang Ye, PhD
Postdoctoral Associate
Center for Infectious Disease Modeling and Analysis (CIDMA)
Yale School of Public Health
yang.ye@yale.edu
Supplement to Response to Request for Technical Assistance
Delivered to Staff of U.S. Senate Committee on Finance
Delivered to Philadelphia City Council
Presented to Staff of U.S. Senate Committee on Finance
Submitted to the U.S. Committee on Ways & Means Subcommittee on Health
Presented to Staff of Rep. GT Thompson (R-PA)